Age at onset of ovarian cancer in women with a strong family history of ovarian cancer

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 3-9

  Goldberg, Jeffrey M ^a   Steven Piver, M ^a   Jishi, Mohannad F ^a   Blumenson, Leslie ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTICIPATION; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; OVARY CANCER; PEDIGREE; PRIORITY JOURNAL; STATISTICS;

EID: 0031194626     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4737     Document Type: Article

References (20)

1. Piver M S, Baker T R, Jishi M F, Sandecki A M, Tsukada Y, Natarajan N, Mettlin C J, Blake C A. Familial ovarian cancer: a report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991. Cancer. 71:1993;582-588.
2. Piver M S, Goldberg J M, Jishi M F, Tsukada Y, Natarajan N. Characteristics of familial ovarian cancer: a report of the first 1000 families in the Gilda Radner Familial Ovarian Cancer Registry. Eur J Obstet Gynaecol. 17:1996;169-176.
3. Lynch H T, Watson P, Bewtra C, Conway T A, Hippee C R, Kaur P, Lynch J F, Ponder B AJ. Hereditary ovarian cancer: heterogeneity in age at diagnosis. Cancer. 67:1991;1460-1466.
4. Amos C I, Shaw G L, Tucker M A, Hartge P. Age at onset for familial epithelial ovarian cancer. JAMA. 268:1992;1896-1899.
5. Houlston R S, Bourne T H, Collins W P, Whitehead M I, Campbell S, Slack J. Risk of ovarian cancer and genetic relationship to other cancers in families. Hum Hered. 43:1993;111-115.
6. L, AG, Ries, B, F, Hankey, B, A, Miller, A, M, Hartman, B, K, Edwards, 1991, Cancer Statistics Review: 1973-1988, National Cancer Institute.
7. Caskey C T, Pizzuti A, Fu Y H, Fenwick R G, Nelson D L. Triplet repeat mutations in human disease. Science. 256:1992;784-789.
8. Harper P S, Harley H G, Reardon W, Shaw D J. Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet. 51:1992;10-16.
9. Cell. 72:1993;971-983.
10. Orr H T, Chung M, Banfi S, Kwiatkowski T J, Servadio A, Beaudet A L, McCall A E, Duvick L A, Ranum L PW, Zoghbi H Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4:1993;221-226.
11. Bassett A S, Honer W G. Evidence for anticipation in schizophrenia. Am J Hum Genet. 54:1994;864-870.
12. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, Endo K, Takahashi H, Kondo R, Ishikawa A, Hayashi T, Saito M, Tomoda A, Miike T, Naito H, Ikuta F, Tsuji S. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet. 6:1994;9-13.
13. Riggins G J, Lokey L K, Chastain J L, Leiner H A, Sherman S L, Wilkinson K D, Warren S T. Human genes containing polymorphic trinucleotide repeats. Nature Genet. 2:1992;186-191.
14. Sutherland G R, Richards R I. Anticipation legitimized: unstable DNA to the rescue. Am J Hum Genet. 51:1992;7-9.
15. Brook J D, McCurrach M E, Harley H G, Buckler A J, Church D, Aburatani H, Hunter K, Stanton V P, Thirion J P, Hudson T, Sohn R, Zemelman B, Snell R G, Rundle S A, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper P S, Shaw D J, Housman D E. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 68:1992;799-808.
16. Schildkraut J M, Risch N, Thompson W D. Evaluating genetic association among ovarian, breast and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet. 45:1989;521-529.
17. Schildkraut J M, Thompson W D. Familial ovarian cancer: a population-based case-control study. Am J Epidemiol. 128:1988;456-466.
18. Kerlikowske K, Brown J S, Grady D G. Should women with familial ovarian cancer undergo prophylactic oopherectomy? Obstet Gynecol. 80:1992;700-707.
19. Kerber R A, Slattery M L. The impact of family history on ovarian cancer risk. Arch Intern Med. 155:1995;905-912.
20. Piver M S, Goldberg J M. Prophylactic Oopherectomy. Controversies in the Management of Ovarian Cancer. 1997;Churchill Livingstone, New York.